Cinclus Pharma Holding AB (publ) (STO: CINPHA)

Cinclus Pharma Holding AB Statistics

Total Valuation

Cinclus Pharma Holding AB has a market cap or net worth of SEK 944.48 million. The enterprise value is 300.66 million.

Market Cap	944.48M
Enterprise Value	300.66M

Important Dates

The next estimated earnings date is Thursday, February 20, 2025.

Earnings Date	Feb 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Cinclus Pharma Holding AB has 46.54 million shares outstanding. The number of shares has increased by 38.66% in one year.

Current Share Class	n/a
Shares Outstanding	46.54M
Shares Change (YoY)	+38.66%
Shares Change (QoQ)	+62.25%
Owned by Insiders (%)	11.22%
Owned by Institutions (%)	16.64%
Float	32.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.56
P/TBV Ratio	1.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.90
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.80, with a Debt / Equity ratio of 0.00.

Current Ratio	14.80
Quick Ratio	14.58
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-13.16M
Employee Count	13
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	22.70
200-Day Moving Average	n/a
Relative Strength Index (RSI)	44.27
Average Volume (20 Days)	119,365

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-151.81M
Pretax Income	-156.91M
Net Income	-157.91M
EBITDA	-151.70M
EBIT	-151.81M
Earnings Per Share (EPS)	-4.94

Balance Sheet

The company has 644.26 million in cash and 440,000 in debt, giving a net cash position of 643.82 million or 13.83 per share.

Cash & Cash Equivalents	644.26M
Total Debt	440,000
Net Cash	643.82M
Net Cash Per Share	13.83
Equity (Book Value)	606.25M
Book Value Per Share	13.03
Working Capital	612.46M

Cash Flow

Operating Cash Flow	-162.88M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Cinclus Pharma Holding AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.66%
Shareholder Yield	-38.66%
Earnings Yield	-24.35%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cinclus Pharma Holding AB has an Altman Z-Score of 15.61.

Altman Z-Score	15.61
Piotroski F-Score	n/a